ISR - IsoRay GAAP EPS of -$0.01 in-line revenue of $2.51M misses by $0.33M
- IsoRay press release ( NYSE: ISR ): FQ4 GAAP EPS of -$0.01 in-line.
- Revenue of $2.51M (-7.4% Y/Y) misses by $0.33M .
- Cash, cash equivalents, and certificates of deposit at the end of the fiscal year ended June 30, 2022 totaled $55.9 million and the company had no long-term debt.
- Stockholders’ equity at the end of the fiscal year ended June 30, 2022 totaled $61.3 million.
- Entered into a definitive agreement to acquire Viewpoint Molecular Targeting.
For further details see:
IsoRay GAAP EPS of -$0.01 in-line, revenue of $2.51M misses by $0.33M